Aug 27 New financial analysis reveals significant savings realized from CYP2C19 testing By Staff Writer Cardiology, Genetics Research, News, Pharmacogenetics Twenty lives and $440,000 over a year. For every 1,000 patients. That’s what CYP2C19 pharmacogenetic testing could save if used to help prescribe clopidogrel (Plavix), prasugrel or ticagrelor to specific…Read More